BioXcel Therapeutics, Inc.
BTAI
$1.31
$0.064.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.60% | -4.82% | -10.43% | -69.02% | -58.17% |
| Total Receivables | -- | 77.86% | -- | -97.91% | -- |
| Inventory | -22.12% | 6.33% | -69.90% | -81.12% | -73.68% |
| Prepaid Expenses | -16.72% | -23.86% | 27.04% | 85.59% | 125.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 771.26% | 683.82% | 48.64% | 29.95% | -25.38% |
| Total Current Assets | -10.24% | 19.50% | -7.09% | -60.67% | -53.31% |
|
|
|||||
| Total Current Assets | -10.24% | 19.50% | -7.09% | -60.67% | -53.31% |
| Net Property, Plant & Equipment | -83.33% | -73.05% | -61.60% | -53.21% | -46.78% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 0.00% |
| Total Assets | -11.77% | 17.16% | -8.39% | -60.59% | -53.15% |
|
|
|||||
| Total Accounts Payable | 5.16% | -8.06% | 9.32% | 25.92% | -10.28% |
| Total Accrued Expenses | 66.67% | -23.04% | -48.86% | -62.18% | -71.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 276.49% | -- | 4,515.22% | 3,077.84% | 1,587.82% |
| Total Finance Division Other Current Liabilities | 4,234.51% | 2,003.66% | -90.64% | -38.98% | 12.44% |
| Total Other Current Liabilities | 4,234.51% | 2,003.66% | -90.64% | -38.98% | 12.44% |
| Total Current Liabilities | 115.27% | 142.55% | 47.92% | 22.31% | -18.85% |
|
|
|||||
| Total Current Liabilities | 115.27% | 142.55% | 47.92% | 22.31% | -18.85% |
| Long-Term Debt | -22.08% | -17.41% | -11.62% | -5.38% | -1.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 105.13% | -73.01% | -17.45% | -71.58% | -84.57% |
| Total Liabilities | 8.41% | 6.80% | -0.61% | -4.49% | -16.77% |
|
|
|||||
| Common Stock & APIC | 10.57% | 12.12% | 11.73% | 3.19% | 4.08% |
| Retained Earnings | -11.46% | -10.75% | -10.67% | -8.14% | -6.49% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -17.05% | -2.54% | -3.84% | -44.91% | -24.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.05% | -2.54% | -3.84% | -44.91% | -24.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.05% | -2.54% | -3.84% | -44.91% | -24.61% |
|
|
|||||